Abstract

Case Report

Refractory priapism associated with anti-psychotics. Report of a case for risperidone

Ramos Luces Odionnys* and Fermín Miriangel and Perdomo Yalisca

Published: 08 May, 2023 | Volume 7 - Issue 2 | Pages: 020-022

Priapism is a prolonged erection, usually painful, that occurs in the absence of sexual desire or stimulation, is not relieved by masturbation or intercourse and is the consequence of a mismatch in the regulatory mechanisms that initiate penile erection and those that allow its detumescence. One of the main causes of low-flow priapism is the use of drugs with an α-adrenergic antagonist effect, among which antipsychotic drugs stand out. Our objective is to present a clinical case and review the literature on the use of antipsychotics in medicine, psychiatry and other specialties and their relationship with the dose of the psychoactive drug in the onset of priapism. We present a 23-year-old male patient, single, with a significant history of mild Autism, for which he has received regular treatment with 6 mg daily of risperidone. He started experiencing priapism spontaneously for the last 4 days until a family member took him to the Emergency Room – intense, persistent and painful penile erection. Given the failure of the initial medical treatment for priapism, it was decided to perform multiple distal cavernous-cancellous shunts with improvement after 72 hours and discharge of the patient. We understand that there is a high affinity of antipsychotics for the α 1-adrenergic receptor, risperidone has an α 1 antagonist capacity. In fact, the third cause of priapism cases induced by atypical antipsychotics is secondary to risperidone, including recent cases associated with its parenteral depot presentation RisperdalConsta®.

Read Full Article HTML DOI: 10.29328/journal.acr.1001070 Cite this Article Read Full Article PDF

Keywords:

Priapism; Antipsychotics; Risperidone

References

  1. Broderick GA, Kadioglu A, Bivalacqua TJ, Ghanem H, Nehra A, Shamloul R. Priapism: pathogenesis, epidemiology, and management. J Sex Med. 2010 Jan;7(1 Pt 2):476-500. doi: 10.1111/j.1743-6109.2009.01625.x. PMID: 20092449.
  2. Burnett AL, Bivalacqua TJ. Priapism: new concepts in medical and surgical management. Urol Clin North Am. 2011 May;38(2):185-94. doi: 10.1016/j.ucl.2011.02.005. PMID: 21621085.
  3. Compton MT, Miller AH. Priapism associated with conventional and atypical antipsychotic medications: a review. J Clin Psychiatry. 2001 May;62(5):362-6. doi: 10.4088/jcp.v62n0510. PMID: 11411819.
  4. Kadioglu A, Sanli O, Celtik M, Cakan M, Taskapu H, Akman T. Practical management of patients with priapism. EAU-EBU update series. 2006; 4: 150-60.
  5. Sood S, James W, Bailon MJ. Priapism associated with atypical antipsychotic medications: a review. Int Clin Psychopharmacol. 2008 Jan;23(1):9-17. doi: 10.1097/YIC.0b013e3282f1c1ef. PMID: 18090503.
  6. Makesar D, Thome J. Risperidone-induced priapism. World J Biol Psychiatry. 2007;8(1):45-7. doi: 10.1080/15622970600797575. PMID: 17366350.

Figures:

Similar Articles

Recently Viewed

Read More

Most Viewed

Read More

Help ?